Literature DB >> 9700139

Manganese superoxide dismutase, but not CuZn superoxide dismutase, is highly expressed in the granulomas of pulmonary sarcoidosis and extrinsic allergic alveolitis.

E Lakari1, P Pääkkö, V L Kinnula.   

Abstract

The role of antioxidant defense mechanisms in the pathogenesis of granulomatous human lung diseases remains open to investigation. In this study we investigated the immunoreactivity of two important superoxide radical scavenging intracellular antioxidant enzymes, manganese superoxide dismutase (MnSOD) and copperzinc superoxide dismutase (CuZnSOD), in pulmonary sarcoidosis and extrinsic allergic alveolitis. In histologically normal lung MnSOD was variable but mostly positive in the cells of bronchial epithelium, alveolar epithelium especially in type II pneumocytes, and alveolar macrophages. Copperzinc SOD showed positive immunoreactivity most markedly in the bronchial epithelium. The biopsies of 22 patients with pulmonary sarcoidosis and 10 with extrinsic allergic alveolitis indicated that MnSOD was highly stained in the granulomas of both diseases, with 60 to 100% of the granulomas showing intensive immunoreactivity. Western blots conducted on the cell samples of bronchoalveolar lavage (BAL) fluid revealed significantly higher amounts of MnSOD in sarcoidosis and extrinsic allergic alveolitis than in the controls. Immunohistochemistry on the cells obtained from BAL fluid showed positive immunoreactivity of MnSOD in the macrophages but not in the lymphocytes. In contrast, copperzinc SOD was not induced in either of these diseases. We conclude that MnSOD is highly expressed in the granulomas of pulmonary sarcoidosis and extrinsic allergic alveolitis, and variable but mostly positive in alveolar macrophages, possibly owing to cytokine mediated induction during the granuloma formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700139     DOI: 10.1164/ajrccm.158.2.9711059

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  13 in total

1.  Peroxiredoxin II expression and its association with oxidative stress and cell proliferation in human idiopathic pulmonary fibrosis.

Authors:  Kirsi Vuorinen; Steffen Ohlmeier; Outi Leppäranta; Kaisa Salmenkivi; Marjukka Myllärniemi; Vuokko L Kinnula
Journal:  J Histochem Cytochem       Date:  2008-07-07       Impact factor: 2.479

Review 2.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

Review 3.  Oxidative stress in COPD and its measurement through exhaled breath condensate.

Authors:  Wei Lee; Paul S Thomas
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

4.  Cell specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis.

Authors:  V L Kinnula; S Lehtonen; R Kaarteenaho-Wiik; E Lakari; P Pääkkö; S W Kang; S G Rhee; Y Soini
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

5.  Expression of thioredoxin in granulomas of sarcoidosis: possible role in the development of T lymphocyte activation.

Authors:  T Koura; Y Gon; S Hashimoto; A Azuma; S Kudoh; Y Fukuda; I Sugawara; J Yodoi; T Horie
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

Review 6.  Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.

Authors:  Irfan Rahman; Vuokko L Kinnula
Journal:  Expert Rev Clin Pharmacol       Date:  2012-05       Impact factor: 5.045

7.  Extracellular superoxide dismutase has a highly specific localization in idiopathic pulmonary fibrosis/usual interstitial pneumonia.

Authors:  V L Kinnula; U A Hodgson; E K Lakari; R J Tan; R T Sormunen; Y M Soini; S J Kakko; T H Laitinen; T D Oury; P K Pääkkö
Journal:  Histopathology       Date:  2006-07       Impact factor: 5.087

Review 8.  Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases.

Authors:  V L Kinnula
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

9.  UDN glycoprotein inhibits activator protein-1 and matrix metalloproteinase-9 via blocking of oxygen radicals in HT-29 cells.

Authors:  Sei-Jung Lee; Kye-Taek Lim
Journal:  Mol Cell Biochem       Date:  2007-04-24       Impact factor: 3.396

10.  Two functional variants of the superoxide dismutase genes in Finnish families with asthma.

Authors:  V L Kinnula; S Lehtonen; P Koistinen; S Kakko; M Savolainen; J Kere; V Ollikainen; T Laitinen
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.